Navigation Links
Use of Vitamin K Antagonists in the Treatment of Atrial Fibrillation is Driven by the Availability of an Oral Formulation, Cost and Widespread Inclusion on Guidelines and Formularies
Date:12/15/2010

MALVERN, Pa., Dec. 15, 2010 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that, in the treatment of atrial fibrillation, surveyed European cardiologists indicate that use of vitamin K antagonists, as a class, is primarily driven by the availability of an oral formulation, overall low cost and widespread inclusion on European medical society guidelines and hospital formularies. Vitamin K antagonists and low molecular weight heparins are the most commonly used anticoagulants across physician specialties in Europe.

"Orally administered vitamin K antagonists tend to dominate prescribing in both in-patient and discharge therapy setting, while low molecular weight heparins are more frequently used in the in-patient setting because of their injectable formulation," said AMR Analyst James Andersen.

The analysis can be found in Hospital Insight Series: Anticoagulants—Stroke Prevention in Atrial Fibrillation (Europe) which will publish later this month. The report analyzes the use of anticoagulants in atrial fibrillation using AMR's comprehensive and highly detailed clinical data in conjunction with primary research and extensive understanding of the market. This report contains European data and examines the reasons behind cardiologists' product preferences, factors driving anticoagulant prescribing patterns and physician receptivity to emerging treatments.

About AMRAMR (www.AMR-data.com) serves the market intelligence needs of the pharmaceutical and diagnostic imaging industries. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits. AMR is a Decision Resources, Inc. company.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Decision Resources, Inc.Christopher Comfort781-296-2597 ccomfort@dresources.com
'/>"/>

SOURCE Arlington Medical Resources
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
2. FDA Cautions on Accurate Vitamin D Supplementation for Infants
3. Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins
4. Mission Pharmacal Launches New Vitamin B6-Rich Prescription Prenatal Vitamin, CitraNatal(R) B-Calm
5. Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins
6. New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults
7. Vitamin E Improves NASH
8. FDA: Procter & Gamble Unlawfully Marketing Two Vicks Cold and Flu Medicines Containing Vitamin C
9. VitaminSpice Appoints Dr. Richard F. Seelig as Director
10. July 2009 Mayo Clinic Womens HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
11. Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. ... ... ... ... Sino-German High-Tech Fund ...
(Date:5/3/2016)... May 3, 2016   BIOTRONIK , a ... announced Food and Drug Administration (FDA) approval of ... provides heart failure patients with access to diagnostic ... have remote monitoring with daily automatic transmission and ... rate in response to physiological demands. ...
(Date:5/3/2016)... DPLO) announced today that it is celebrating Hepatitis Awareness Month with a campaign to honor ... story and encourage those at risk to get tested and begin the road to a ... ... ... Pharmacy, Inc.) ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... , ... LELO has discovered many people are insecure about their ... email, social media and on the Volonté blog seeking advice about how to actually ... or ‘correct’?” , While some methods are more common than others, there is no ...
(Date:5/5/2016)... ... May 05, 2016 , ... An essential tool ... states and certain Canadian provinces is now available from the International Association of ... , The report, Workers’ Compensation Laws as of January 1, 2016, ...
(Date:5/5/2016)... York (PRWEB) , ... May 05, 2016 , ... Long ... announced the merger of noted Long Island eye surgeon, Kathleen Van Valkenburg, MD as ... practice, according to Jeffrey Martin, MD, medical director and managing partner of North Shore ...
(Date:5/5/2016)... ... May 05, 2016 , ... Standard Process Inc. ... across the United States. The whole food nutrient solutions company can help veterinarians ... dog, cat and horse owners’ peace of mind. With the increased support, veterinarian ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... to people’s every day living patterns, Amerec, a Seattle-based steam bath and sauna ... phone app. , The user interface of the app, developed for both smartphones ...
Breaking Medicine News(10 mins):